Blending Clinical Practice and Research

To view a presentation, click on it's title (below the speaker's affiliation). To save a presentation, right click it's title and choose "Save Target As."

All presentations are in Adobe Acrobat .pdf format. If you do not have Adobe Acrobat, you can download it for free here.

Please check this page in the future for presentations that are not currently posted. Presentations are uploaded as they are received.

Progress in Translating Drug Abuse Research Into Clinical Practice

Nora D. Volkow, M.D.
Director
National Institute on Drug Abuse
National Institutes of Health
Progress in Translating Drug Abuse Research into Clinical Practice

Disease Management: Addiction as a Chronic Relapsing Disease

Thomas Carli, M.D.
Medical Director
Medical Management Center
at the University of Michigan Health System
New Health Care Models for Managing Chronic Illness: Lessons for Addiction Treatment

Blending Clinical Practice and Research Workshops

1. Methamphetamine: Epidemiology, Neurotoxicity, and Treatment

Charles R. Schuster, Ph.D.
Wayne State University School of Medicine
Methamphetamine Abuse: Epidemiology, Neurotoxicity and Treatment

Chris-Ellyn Johanson, Ph.D.
Wayne State University School of Medicine
Neurotoxic Consequences of High Dose Methamphetamibe Abuse

Patricia Marinelli-Casey, Ph.D., MFT
University of California, Los Angeles
The CSAT Methamphetamine Treatment Project

Anna Talamo, M.A., MFT
East Bay Recovery Project

2. Motivational Interviewing: What It Is, How It Works, and How To Make It Work in Your Agency

William R. Miller, Ph.D.
University of New Mexico
Motivational Interviewing: What It Is, How It Works, and How To Make It Work in Your Agency

Steven J. Ondersma, Ph.D.
Wayne State University

Ned Snead, M.S.
Chesterfield Department of Mental Health, Mental Retardation and Substance Abuse Services
Chesterfield Substance Abuse Services: One Agency's Journey of Change

3. Buprenorphine: From Basic Human Research to Clinical Application
Buprenorphine: From Basic Human Research to Clinical Application (panel discussion slides)

Mark Greenwald, Ph.D.
Wayne State University School of Medicine
Burprenorphine's Effects on Brain Function and Behavior: Clinical Implications

Walter Ling, M.D.
University of California, Los Angeles
Buprenorphine: View from the Clinician

The Science Behind Buprenorphine (exit slides)

Virginia S. Ryan, Ph.D.
SHAR Inc. Residential Substance Abuse Treatment
Buprenorphine: From Basic Human Research to Clinical Application

Allan J. Cohen, M.A., MFT
Bay Area Addiction Research & Treatment, Inc.
Buprenorphine in the Clinical Trials Network: The Community Treatment Provider Experience and Legacy

4. Transitions Across Stages and Levels of Drug Involvement

James C. Anthony, Ph.D., M.Sc.
Michigan State University

Richard Spoth, Ph.D.
Iowa State University

Arin M. Connell, Ph.D.
University of Oregon
Substance Use Trajectories Across Early Adolescence: Linking Intervention, Family and Peer Processes

Ty A. Ridenour, Ph.D., M.P.E.
Pennsylvania State University
ALEXSA Development: Assessment to Bridge Etiology, Prevention, and Clinical Efforts Regarding Early Substance Probelms

5. Treatment on Demand: How It Has Affected the Cities of Baltimore, Detroit, Philadelphia, and San Francisco

Yvonne E. Anthony, Ph.D., M.B.A., M.H.A.
Detroit Department of Health and Wellness Promotion

Calvin R. Trent, Jr., Ph.D., M.Ed.
Detroit Department of Health and Wellness Promotion
Treatment of Demand: A Public Policy Initiative of the City of Detroit

Joseph Guydish, Ph.D., M.P.H.
University of California at San Francisco
San Francisco: Drug Treatment on Demand

Melisa M. Lindamood, M.P.S.
Baltimore City Health Department

Mark Bencivengo, M.A.
Philadelphia Health Management Corporation
City of Philadelphia: Behavioral Health Opportunities for Recovery

6. Addressing Medical and Psychiatric Needs in Substance Abuse Treatment

Michael R. Liepman, M.D.
Michigan State University
Case Study of a Residential Treatment Center

Jeffrey Selzer, M.D.
Zucker Hillside Hospital
Addressing Medical and Psychiatric Needs in Substance Abuse Treatment

John A. Hopper, M.D.
Wayne State University School of Medicine
Addressing Medical and Psychiatric Needs in Substance Abuse Treatment

Kathleen A. Sheenan, M.S.N., R.N.
Zucker Hillside Hospital
Treatment Planning

Anne C. Benion, M.S.S., ACSW
SHAR Inc. Residential Substance Abuse Treatment

7. Behavioral Therapies in Substance Abuse Treatment: Contingency Management and Cognitive Behavioral Therapy

Kathleen M. Carroll, Ph.D.
Yale University School of Medicine

Maxine L. Stitzer, Ph.D.
Johns Hopkins University School of Medicine

Gary Rhodes, M.A., LLP
Wayne State University
University Psychiatric Centers - Jefferson Avenue Research Clinic

8. Co-Occurring Disorders in Substance Abuse Treatment

Kathleen T. Brady, M.D., Ph.D.
Medical University of South Carolina
Evidence-Based Treatments for Comorbid Substance Use and Psychiatric Disorders

Bruce Rounsaville, M.D.
Yale University School of Medicine
Treating Mental Illness in Drug Abusers

Eric E. Schindler, Ph.D.
La Frontera Center, Inc.
Co-Occurring Disorders Treatment Challenges: Provider Perspective

9. Women and Comorbidity

Cynthia L. Arfken, Ph.D.
Wayne State University

Sheryl Pimlott Kubiak, Ph.D., M.S.W.
Wayne State University
Treatment Considerations for Women with Co-occurring Psychiatric and Substance Use Disorders

Shelly F. Greenfield, M.D., M.P.H.
McLean Hospital
Depression and Substance Use Disorders Women and Co-Morbidity Workshop

Susan M. Gordon, Ph.D.
Caron Foundation
Eating Disorders and Substance Use Disorders

Gloria M. Miele, Ph.D.
Columbia University
PTSD and Substance Abuse

10. Treatment Interventions To Prevent the Next Generation of Substance Abuse: Family-Based Approaches

Robert A. Zucker, Ph.D.
University of Michigan
Treatment Interventions To Prevent the Next Generation of Substance Abuse: Family-Based Approaches

Deborah A. Ellis, Ph.D., M.A.
Children's Hospital of Michigan / Wayne State University
Strengthening Families Program: The Evidence Base for Effective Intervention and Prevention

Karol Kumpfer, Ph.D.
University of Utah
Treatment Interventions To Prevent the Next Generation of Substance Abuse: Family-Based Approaches

Foxcroft Article

Drug Abuse Findings by Mike Aston

11. Evidence-Based Practice: What It Means to the Provider

Joseph Rosenfeld, Psy.D., CRADC
Rosenfeld & Associates
Evidence-Based Practice: What it means to the Provider

Lonnetta Albright
Great Lakes Addiction Technology Transfer Center

Steven L. Gallon, Ph.D.
Northwest Frontier Addiction Technology Transfer Center

Gregory S. Brigham, Ph.D.
Maryhaven, Inc.
Moving Buprenorphine-Naloxone Treatment for Short-term Medically Managed Opioid Withdrawal from a Phase Three National Multi-site RCT to Maryhaven, a Community Treatment Program

DSC Annual Strategic Plan Review

12. Adjusting Intensity of Substance Abuse Treatment to Patient Need

Robert K. Brooner, Ph.D.
Johns Hopkins Bayview Medical Center

Ron Jackson, M.S.W.
Evergreen Treatment Services

James R. McKay, Ph.D.
University of Pennsylvania
Using Progress in Intensive Outpatient Treatment to Select Appropriate Continuing Care

Lawrence S. Brown, Jr., M.D., M.P.H., FASAM
American Society of Addiction Medicine

4. Best Practice in Addiction Treatment: How To Improve Skills as a Consumer of Research










		To view a presentation, click on it's title (below the speaker's affiliation). To save a presentation, right click it's title and choose "Save Target As." All presentations are in Adobe Acrobat .pdf format. If you do not have Adobe Acrobat, you can download it for free here. Please check this page in the future for presentations that are not currently posted. Presentations are uploaded as they are received. Progress in Translating Drug Abuse Research Into Clinical Practice Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes of Health Progress in Translating Drug Abuse Research into Clinical Practice Disease Management: Addiction as a Chronic Relapsing Disease Thomas Carli, M.D. Medical Director Medical Management Center at the University of Michigan Health System New Health Care Models for Managing Chronic Illness: Lessons for Addiction Treatment Blending Clinical Practice and Research Workshops 1. Methamphetamine: Epidemiology, Neurotoxicity, and Treatment Charles R. Schuster, Ph.D. Wayne State University School of Medicine Methamphetamine Abuse: Epidemiology, Neurotoxicity and Treatment Chris-Ellyn Johanson, Ph.D. Wayne State University School of Medicine Neurotoxic Consequences of High Dose Methamphetamibe Abuse Patricia Marinelli-Casey, Ph.D., MFT University of California, Los Angeles The CSAT Methamphetamine Treatment Project Anna Talamo, M.A., MFT East Bay Recovery Project 2. Motivational Interviewing: What It Is, How It Works, and How To Make It Work in Your Agency William R. Miller, Ph.D. University of New Mexico Motivational Interviewing: What It Is, How It Works, and How To Make It Work in Your Agency Steven J. Ondersma, Ph.D. Wayne State University Ned Snead, M.S. Chesterfield Department of Mental Health, Mental Retardation and Substance Abuse Services Chesterfield Substance Abuse Services: One Agency's Journey of Change 3. Buprenorphine: From Basic Human Research to Clinical Application Buprenorphine: From Basic Human Research to Clinical Application (panel discussion slides) Mark Greenwald, Ph.D. Wayne State University School of Medicine Burprenorphine's Effects on Brain Function and Behavior: Clinical Implications Walter Ling, M.D. University of California, Los Angeles Buprenorphine: View from the Clinician The Science Behind Buprenorphine (exit slides) Virginia S. Ryan, Ph.D. SHAR Inc. Residential Substance Abuse Treatment Buprenorphine: From Basic Human Research to Clinical Application Allan J. Cohen, M.A., MFT Bay Area Addiction Research & Treatment, Inc. Buprenorphine in the Clinical Trials Network: The Community Treatment Provider Experience and Legacy 4. Transitions Across Stages and Levels of Drug Involvement James C. Anthony, Ph.D., M.Sc. Michigan State University Richard Spoth, Ph.D. Iowa State University Arin M. Connell, Ph.D. University of Oregon Substance Use Trajectories Across Early Adolescence: Linking Intervention, Family and Peer Processes Ty A. Ridenour, Ph.D., M.P.E. Pennsylvania State University ALEXSA Development: Assessment to Bridge Etiology, Prevention, and Clinical Efforts Regarding Early Substance Probelms 5. Treatment on Demand: How It Has Affected the Cities of Baltimore, Detroit, Philadelphia, and San Francisco Yvonne E. Anthony, Ph.D., M.B.A., M.H.A. Detroit Department of Health and Wellness Promotion Calvin R. Trent, Jr., Ph.D., M.Ed. Detroit Department of Health and Wellness Promotion Treatment of Demand: A Public Policy Initiative of the City of Detroit Joseph Guydish, Ph.D., M.P.H. University of California at San Francisco San Francisco: Drug Treatment on Demand Melisa M. Lindamood, M.P.S. Baltimore City Health Department Mark Bencivengo, M.A. Philadelphia Health Management Corporation City of Philadelphia: Behavioral Health Opportunities for Recovery 6. Addressing Medical and Psychiatric Needs in Substance Abuse Treatment Michael R. Liepman, M.D. Michigan State University Case Study of a Residential Treatment Center Jeffrey Selzer, M.D. Zucker Hillside Hospital Addressing Medical and Psychiatric Needs in Substance Abuse Treatment John A. Hopper, M.D. Wayne State University School of Medicine Addressing Medical and Psychiatric Needs in Substance Abuse Treatment Kathleen A. Sheenan, M.S.N., R.N. Zucker Hillside Hospital Treatment Planning Anne C. Benion, M.S.S., ACSW SHAR Inc. Residential Substance Abuse Treatment 7. Behavioral Therapies in Substance Abuse Treatment: Contingency Management and Cognitive Behavioral Therapy Kathleen M. Carroll, Ph.D. Yale University School of Medicine Maxine L. Stitzer, Ph.D. Johns Hopkins University School of Medicine Gary Rhodes, M.A., LLP Wayne State University University Psychiatric Centers - Jefferson Avenue Research Clinic 8. Co-Occurring Disorders in Substance Abuse Treatment Kathleen T. Brady, M.D., Ph.D. Medical University of South Carolina Evidence-Based Treatments for Comorbid Substance Use and Psychiatric Disorders Bruce Rounsaville, M.D. Yale University School of Medicine Treating Mental Illness in Drug Abusers Eric E. Schindler, Ph.D. La Frontera Center, Inc. Co-Occurring Disorders Treatment Challenges: Provider Perspective 9. Women and Comorbidity Cynthia L. Arfken, Ph.D. Wayne State University Sheryl Pimlott Kubiak, Ph.D., M.S.W. Wayne State University Treatment Considerations for Women with Co-occurring Psychiatric and Substance Use Disorders Shelly F. Greenfield, M.D., M.P.H. McLean Hospital Depression and Substance Use Disorders Women and Co-Morbidity Workshop Susan M. Gordon, Ph.D. Caron Foundation Eating Disorders and Substance Use Disorders Gloria M. Miele, Ph.D. Columbia University PTSD and Substance Abuse 10. Treatment Interventions To Prevent the Next Generation of Substance Abuse: Family-Based Approaches Robert A. Zucker, Ph.D. University of Michigan Treatment Interventions To Prevent the Next Generation of Substance Abuse: Family-Based Approaches Deborah A. Ellis, Ph.D., M.A. Children's Hospital of Michigan / Wayne State University Strengthening Families Program: The Evidence Base for Effective Intervention and Prevention Karol Kumpfer, Ph.D. University of Utah Treatment Interventions To Prevent the Next Generation of Substance Abuse: Family-Based Approaches Foxcroft Article Drug Abuse Findings by Mike Aston 11. Evidence-Based Practice: What It Means to the Provider Joseph Rosenfeld, Psy.D., CRADC Rosenfeld & Associates Evidence-Based Practice: What it means to the Provider Lonnetta Albright Great Lakes Addiction Technology Transfer Center Steven L. Gallon, Ph.D. Northwest Frontier Addiction Technology Transfer Center Gregory S. Brigham, Ph.D. Maryhaven, Inc. Moving Buprenorphine-Naloxone Treatment for Short-term Medically Managed Opioid Withdrawal from a Phase Three National Multi-site RCT to Maryhaven, a Community Treatment Program DSC Annual Strategic Plan Review 12. Adjusting Intensity of Substance Abuse Treatment to Patient Need Robert K. Brooner, Ph.D. Johns Hopkins Bayview Medical Center Ron Jackson, M.S.W. Evergreen Treatment Services James R. McKay, Ph.D. University of Pennsylvania Using Progress in Intensive Outpatient Treatment to Select Appropriate Continuing Care Panel Discussion Issues of Race and Ethnicity in Substance Abuse Treatment Jos� Szapocznik, Ph.D. University of Miami Issues of Race and Ethnicity in Substance Abuse Treatment Daniel A. Santisteban, Ph.D. University of Miami The Role of Ethnicity-Related Variables in the Development and Treatment of Substance Abuse in Hispanics R. Dale Walker, M.D., Oregon Health and Science University A National Strategy for Native Addictions Treatment and Prevention: Issues of Race and Ethnicity Lawrence S. Brown, Jr., M.D., M.P.H., FASAM American Society of Addiction Medicine Blending Clinical Practice and Research Optional Mini-Courses 1. An Introduction to Motivational Interviewing Steven J. Ondersma, Ph.D. Wayne State University School of Medicine 2. Buprenorphine for the Treatment Team Susan M. Stine, M.D., Ph.D. Wayne State University Buprenorphine for the Treatment Team Laura F. McNicholas, M.D., Ph.D. Philadelphia VA Medical Center Buprenorphine: A New Medication for the Treatment of Opioid Dependence Albert L. Hasson, M.S.W. University of California, Los Angeles Counseling Buprenorphine Patients - Information and Treatment Approaches for Counselors 3. Issues Related to HIV and Hepatitis C in Substance Abuse John A. Hopper, M.D. Psychiatry and Behavioral Medicine Professionals Blending Clinical Practice and Research: Hiv and Hepatitis C in Substance Abuse Website Links Listing Jeffrey Samet, M.D., M.A., M.P.H. Boston University School of Medicine 4. Best Practice in Addiction Treatment: How To Improve Skills as a Consumer of Research Steven L. Gallon, Ph.D. Northwest Frontier Addiction Technology Transfer Center Joseph Rosenfeld, Psy.D., CRADC Rosenfeld & Associates Research Wendy Hausotter, M.P.H. Northwest Frontier Addiction Technology Transfer Center �Architecture� of a Journal Article



	Who Should Attend \| Conference Topics \| Logistics \| Registration \| Conference Partners \| Continuing Education \| Home